A Comparison of Verapamil and Digoxin for Heart Rate Control in Atrial Fibrillation
A Comparison of Verapamil and Digoxin for Heart Rate Control in Atrial Fibrillation
نویسندگان: کاووس شهسواری نیا , عطا محمودپور
کلمات کلیدی: Digoxin Verapamil, Treatment, Atrial fibrillation
نشریه: 951 , 2 , 2 , 2012
| نویسنده ثبت کننده مقاله |
عطا محمودپور |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده پزشکی |
| کد مقاله |
72627 |
| عنوان فارسی مقاله |
A Comparison of Verapamil and Digoxin for Heart Rate Control in Atrial Fibrillation |
| عنوان لاتین مقاله |
A Comparison of Verapamil and Digoxin for Heart Rate Control in Atrial Fibrillation |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح دو – PubMed |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Purpose: Atrial fibrillation (AF) is one of the most common types of sustained
dysrhythmia and there are some disagreements about its treatment. The goals of AF
treatment include the control of ventricular rate, the establishment of sinus rhythm and
the prevention of thromboembolic events. In this study, the effect of verapamil was
compared to digoxin on heart rate control in patients with AF. Methods:This descriptive
study was conducted in an emergency department (ED) in Iran. Sixty patients with a
new onset AF and rapid ventricular response receiving digoxin or verapamil were
included and observed. Results:Two thirty-patient groups receiving verapamil or
digoxin were evaluated. The heart rate was significantly decreased in both groups (p =
0.002); however, the cardioversion was not noticed in both of them. The best rate
control in verapamil and digoxin groups was observed after 5.9 mg (46.7%) and 0.6 mg
(36.7%), respectively. Conclusion: Administration of verapamil in comparison with
digoxin has no difference to control the heart rate in AF patients. It should be taken into
consideration that prospective randomized studies should be conducted to identify the
efficacy and select the best of these two drugs to treat AF patients. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| APB-2-201.pdf | 1399/03/31 | 406151 | دانلود |